Scientists from Merck and the Walter and Eliza Hall Institute of Medical Research Discover Novel Class of Candidate Anti Malaria Agents that Block Multiple Stages of the Lifecycle of the Parasite
Dateline City:
KENILWORTH, N.J. & MELBOURNE, Australia
Preclinical Data on Candidate Anti Malaria Agents Published in Cell Host & Microbe
KENILWORTH, N.J. & MELBOURNE, Australia–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, today announced the publication of research on the discovery of a novel class of candidate antimalarial agents that block multiple stages of the lifecycle of the parasite that causes the disease.
Language:
English
Contact:
Merck Contact: Claire Mulhearn
908-200-1889
WEHI Contact: Liz Williams
+61 475 751 811
Ticker Slug:
Ticker:
MRK
Exchange:
NYSE
@Merck
